Day: November 29, 2019

WINNIPEG, Manitoba, Nov. 29, 2019 (GLOBE NEWSWIRE) — Empire Industries Ltd. (TSX-V: EIL, OTC:ERILF) (“Empire”, “EIL”, “us”, “our”, “we” or the “Company”) today reported its unaudited consolidated financial results for the third quarter ended September 30, 2019.  The unaudited consolidated financial statements and MD&A have been filed on SEDAR and can be viewed at sedar.com or at empind.com.“We continue to generate positive EBITDA results, with $2.1 million in 3Q19, even though our revenues of $27 million in the quarter were lower than we had expected at the beginning of the year,” said Guy Nelson, Executive Chairman and Chief Executive Officer of Empire.  “A large part of our efforts are focused on final commissioning activities for a record number of rides concurrently; three of the most complex ride systems ever designed...

CALGARY, Alberta, Nov. 29, 2019 (GLOBE NEWSWIRE) — Cuda Oil and Gas Inc. (“Cuda” or the “Company”) (TSXV: CUDA) is pleased to announce that it has entered into an Agreement with the Company’s institutional lender (the “Lender”) to extend the expiration of its 2nd Lien Facility from December 31, 2019 to March 31, 2020. In addition, the Lender has agreed to advance funding of $4.5 MM CAD under the 2nd Lien Facility.  The capital proceeds will be used to fund oil field development expenditures associated with the Company’s Barron Flats Shannon Unit (SSRU) in Converse County, Wyoming.Glenn Dawson, President and Chief Execuitve Officer of Cuda, stated: “The extension and expansion of the 2nd Lien Facility speaks to the confidence in our asset in the Powder River Basin and our progress to advance the miscible gas-flood program. We look...

TORONTO, Nov. 29, 2019 (GLOBE NEWSWIRE) — Feronia Inc. (“Feronia” or the “Company”) (TSX-V: FRN) today released its unaudited financial results for the three and nine months ended September 30, 2019 (“Q3 2019”). All amounts in this release are expressed in US dollars unless otherwise indicated.Q3 2019 HighlightsProduced 46,320 tonnes of fruit (Q3 2018: 52,844 tonnes), a year-over-year decrease of 12%Produced 9,016 tonnes of Crude Palm Oil (“CPO”) (Q3 2018: 11,078 tonnes), a year-over-year decrease of 19%Revenue of $7.7 million (Q3 2018: $6.9 million), a year-over-year increase of 12%, primarily from the sale of 11,265 tonnes of CPO at an average price of $645 per tonne (Q3 2018: 8,750 tonnes at $784 per tonne)Net loss for Q3 2019 of $2.9 million (Q3 2018 net loss: $2.2 million)EBITDA loss for Q3 2019 of $422,000 (Q3 2018 EBITDA:...

FRANKLIN, Ind., Nov. 29, 2019 (GLOBE NEWSWIRE) — IBC Advanced Alloys Corp. (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF) announces that in accordance with the terms of a debenture indenture entered into between the Company and Computershare Trust Company of Canada (“Computershare”) dated June 6, 2018, as supplemented (the “Debenture Indenture”) and the terms of a convertible debenture indenture entered into between the Company and Computershare dated June 6, 2018, as supplemented (the “Convertible Debenture Indenture” and together with the Debenture Indenture, the “Indentures”), it has elected to issue common shares in the capital of the Company (“Common Shares”) to holders of 9.50% unsecured debentures due June 6, 2023 (the “9.50% Debentures”) and 8.25% convertible unsecured debentures due June 6, 2023 (the “8.25% Debentures”...

Transformational acquisition establishes Knight as a premiere pan-American (ex-US) specialty pharma companyMONTREAL, Nov. 29, 2019 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”) today announced that it has completed the acquisition of a 51.2% interest in Biotoscana Investments S.A. (B3: GBIO33) (“GBT” or “Grupo Biotoscana”) from a controlling shareholder group that includes Advent International and Essex Woodlands, among others. As announced on October 21, 2019, Knight paid BRL 10.96 per share or BRL 596 million (C$187 million(1)) (“Purchase Price”) in cash consideration for this controlling interest in GBT.  Knight now controls the board of directors of GBT.An amount equivalent to 20% of the Purchase Price has been deposited in escrow to secure the sellers’ indemnification obligations under the Share...

Cette acquisition transformationnelle établit Knight comme première société pharmaceutique spécialisée et chef de file panaméricaine (excluant les États-Unis)MONTRÉAL, 29 nov. 2019 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou « la Société »), a annoncé aujourd’hui le parachèvement de l’acquisition d’une participation de 51,2 % dans Biotoscana Investments S.A. (B3 : GBIO33) (« GBT » ou « Grupo Biotoscana ») auprès d’un groupe d’actionnaires avec contrôle comprenant Advent International et Essex Woodlands, entre autres. Comme annoncé en date du 21 octobre 2019, Knight a payé 10,96 BRL par action, soit 596 millions de BRL (187 millions de $ CA)(1) (le « prix d’achat ») en liquidités en contrepartie de cette participation majoritaire dans GBT. Knight contrôle désormais le conseil d’administration de GBT.Un...

Geochemical Results Outline Large Arsenic and Gold Trend on the Moose River Anticline, 4 km Southwest of St Barbara’s Touquoy MineHALIFAX, Nova Scotia, Nov. 29, 2019 (GLOBE NEWSWIRE) — MegumaGold Corp. (CSE: NSAU, OTC: NSAUF, FWB: 2CM2) (“MegumaGold” or the “Company”) is pleased to announce additional soil geochemical results with elevated arsenic and gold values for its Touquoy West Project (“Touquoy West”). These results, combined with the results disclosed earlier by the Company (see our press release dated November 19, 2019), define large gold-arsenic anomalies trending along the west extension of the Moose River anticline which hosts St Barbara Ltd.’s open pit Touquoy Gold Mine. This anticline can be traced along an aeromagnetic trend that extends across MegumaGold’s Touquoy West holding and continues through the Touquoy Gold...

Q2 2019 Metoject™ unit market demand increased 115%1;Rasuvo™ unit market demand increased 15%2; andRupall™ unit market demand increased 66%3Medexus management to host conference call at 8:00 AM ET on Monday, December 2, 2019TORONTO and CHICAGO and MONTREAL, Nov. 29, 2019 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today provided a business update and announced its financial and operating results for the three- and six-month periods ended September 30, 2019.  All dollar amounts below are in Canadian dollars.Q2 2020 Financial highlights*:Revenue was $16.4 million compared to $3.4 million for the fiscal quarter ended September 30, 2018 (Q2 2019)Gross profit was $9.6 million compared to $1.9 million for Q2 2019Gross margin was 58.6% compared to 53.8% for Q2 2019Adjusted EBITDA**...

TORONTO, Nov. 29, 2019 (GLOBE NEWSWIRE) — Itafos (TSX VENTURE: IFOS) (the “Company”) reported today its Q3 2019 financial results and operational highlights. The Financial Statements and Management’s Discussion and Analysis for the quarter ended September 30, 2019 are available under the Company’s profile at www.sedar.com and under the Investors – Financial Statements page of the Company’s website, www.itafos.com. All dollar values referenced in this news release are unaudited amounts in thousands of US Dollars except as otherwise noted.Overall HighlightsFor the three months ended September 30, 2019, the Company’s overall highlights were as follows:experienced significant and continued downward pressure on fertilizer prices in key markets including North America and Brazil;continued strong operational and environmental, health and...

Highlights: